Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment.

Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment.

BACKGROUND: Chronic heart failure (CHF) is a major cause of morbidity and mortality that requires a novel approach to therapy. Perhexiline is an antianginal drug that augments glucose metabolism by blocking muscle mitochondrial free fatty acid uptake, thereby increasing metabolic efficiency. We asse...

Podrobná bibliografie
Hlavní autoři:	Lee, L, Campbell, R, Scheuermann-Freestone, M, Taylor, R, Gunaruwan, P, Williams, L, Ashrafian, H, Horowitz, J, Fraser, A, Clarke, K, Frenneaux, M
Médium:	Journal article
Jazyk:	English
Vydáno:	2005

Podobné jednotky

Augmentation of glucose metabolism with perhexiline in non-ischaemic heart failure
Autor: Lee, L, a další
Vydáno: (2004)

Perhexiline.
Autor: Ashrafian, H, a další
Vydáno: (2007)

Effects of perhexiline on ketone body and triglyceride synthesis in patients with refractory angina or heart failure
Autor: Shivu, G, a další
Vydáno: (2008)

Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy.
Autor: Abozguia, K, a další
Vydáno: (2010)

Metabolic Modulation With Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy
Autor: Abozguia, K, a další
Vydáno: (2009)

Metabolic modulation in heart failure: the coming of age.
Autor: Ashrafian, H, a další
Vydáno: (2007)

The pathophysiology of heart failure: a tale of two old paradigms revisited.
Autor: Ashrafian, H, a další
Vydáno: (2008)

Metabolic mechanisms in heart failure.
Autor: Ashrafian, H, a další
Vydáno: (2007)

METABOLIC ALTERATION IN HYPERTROPHIC CARDIOMYOPATHY (METAL-HCM STUDY): RANDOMISED DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF PERHEXILINE THERAPY IN PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
Autor: Abozguia, K, a další
Vydáno: (2010)

Changes in the cardiac metabolome caused by perhexiline treatment in a mouse model of hypertrophic cardiomyopathy.
Autor: Gehmlich, K, a další
Vydáno: (2014)

Abnormal cardiac and skeletal muscle function and energetics correlate with insulin resistance in heart failure
Autor: Scheuermann-Freestone, M, a další
Vydáno: (2004)

Impaired energetics in heart failure - a new therapeutic target.
Autor: Ormerod, J, a další
Vydáno: (2008)

Perhexiline Therapy in Patients with Type 2 Diabetes: Incremental Insulin Resistance despite Potentiation of Nitric Oxide Signaling
Autor: Cher-Rin Chong, a další
Vydáno: (2022-09-01)

Prevalence of heart failure preserved ejection fraction in the community
Autor: Mahadevan, G, a další
Vydáno: (2007)

Modification of myocardial substrate use as a therapy for heart failure.
Autor: Abozguia, K, a další
Vydáno: (2006)

Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation
Autor: Bimala Dhakal, a další
Vydáno: (2023-03-01)

Hypoxic modulation of exogenous nitrite-induced vasodilation in humans.
Autor: Maher, A, a další
Vydáno: (2008)

Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
Autor: Gabriela Reyes-Castellanos, a další
Vydáno: (2023-06-01)

Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects
Autor: Bimala Dhakal, a další
Vydáno: (2023-04-01)

Systemic nitrite selectively dilates veins and pulmonary vasculature, relieving diastolic ventricular interaction in advanced heart failure
Autor: Ormerod, J, a další
Vydáno: (2009)

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy
Autor: Tobias J. Pfeffer, a další
Vydáno: (2021-08-01)

Abnormal cardiac high-energy phosphate metabolism in a patient with type 2 diabetes mellitus.
Autor: Scheuermann-Freestone, M, a další
Vydáno: (2006)

Metabolic modulation in heart failure: high time for a definitive clinical trial.
Autor: Ashrafian, H, a další
Vydáno: (2011)

Effect of chronic peroxisome proliferator-activated receptor gamma (PPAR gamma) activation on cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes mellitus
Autor: Scheuermann-Freestone, M, a další
Vydáno: (2004)

Pacing in congestive heart failure
Autor: Frenneaux Michael P, a další
Vydáno: (2000-10-01)

The pathophysiology of heart failure
Autor: Ashrafian, H, a další
Vydáno: (2002)

DYNAMIC CHANGES IN LEFT VENTRICULAR FUNCTION ON EXERCISE IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE ROLE OF MYOCARDIAL ENERGY DEFICIENCY
Autor: Phan, T, a další
Vydáno: (2009)

Cardiac and skeletal muscle metabolism after chronic PPAR gamma activation in type 2 diabetes mellitus
Autor: Scheuermann-Freestone, M, a další
Vydáno: (2004)

Cardiac energetics in congestive heart failure.
Autor: Ashrafian, H
Vydáno: (2002)

Response to letter regarding article, "The effect of selective heart rate slowing in heart failure with preserved ejection fraction"
Autor: Pal, N, a další
Vydáno: (2016)

Impaired active relaxation during dynamic exercise in patients with heart failure with a preserved ejection fraction (HfpEF)
Autor: Phan, T, a další
Vydáno: (2008)

Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency.
Autor: Phan, T, a další
Vydáno: (2009)

Chronic oral ascorbic acid therapy worsens skeletal muscle metabolism in patients with chronic heart failure.
Autor: Nightingale, A, a další
Vydáno: (2007)

Genetic cardiomyopathies causing heart failure.
Autor: Cahill, T, a další
Vydáno: (2013)

New therapies for heart failure: is thalidomide the answer?
Autor: Davey, P, a další
Vydáno: (2000)

Despite improving endothelial function oral vitamin C increases phosphocreatine depletion during exercise in patients with chronic heart failure
Autor: Nightingale, A, a další
Vydáno: (2002)

Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
Autor: Alessandra Guidi, a další
Vydáno: (2016-08-01)

Modulation of cardiac energetics as a target in ischemic heart disease
Autor: Ashrafian, H
Vydáno: (2011)

Haemoglobin and flow-mediated vasodilation.
Autor: Madsen, P, a další
Vydáno: (2006)

PPARgamma activation improves cardiac energy metabolism in patients with type 2 diabetes Mellitus
Autor: Scheuermann-Freestone, M, a další
Vydáno: (2003)